Literature DB >> 18598654

Bartonella quintana and Coxiella burnetii as causes of endocarditis, India.

Nandhakumar Balakrishnan, Thangam Menon, Pierre-Edouard Fournier, Didier Raoult.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18598654      PMCID: PMC2600341          DOI: 10.3201/eid1407.071374

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: In industrialized countries, blood culture is negative for 2.5%–31% of infectious endocarditis cases (). In developing countries such as South Africa (), Algeria (), and Pakistan (), culture is negative for 48% to 56%. Negative cultures delay diagnosis and treatment, which profoundly affects clinical outcome. Negative blood cultures commonly result from previous administration of antimicrobial drugs, right-sided endocarditis, or fastidious or noncultivable pathogens (). Our aim was to identify fastidious agents of blood culture–negative endocarditis by serology. Because of recent attention to zoonotic microorganisms as agents of this condition in developing countries (), we investigated the prevalence of Coxiella burnetii, Bartonella spp., and Brucella melitensis among endocarditis patients in India. We cultured blood from 111 patients admitted to the Government General Hospital, Chennai, India, from August 2005 through December 2006, with a diagnosis of infectious endocarditis according to the Duke criteria (). Informed consent was obtained from all patients. Three blood samples from each patient, collected at hourly intervals, were inoculated into brain–heart infusion broth supplemented with 0.04% sodium polyanethol sulfonate (HiMedia, Mumbai, India). Cultures were incubated at 37°C in a 5% CO2 atmosphere for 14 days and checked each day for turbidity. Subcultures were made on 5% sheep blood and MacConkey agar at 37°C at 24 hours, 48 hours, and when culture broth appeared turbid. Blood cultures were negative for 80 (72%) of the 111 patients. Serum from 63 patients was available for serologic testing. Of these patients, 30 were male and 33 were female; age range was 5–65 years and mean age was 25.5 years. Endocarditis involved the native valve for 60 (95.23%) and a prosthetic valve for 3 (4.76%). The most frequent predisposing factor was rheumatic heart disease, found in 38 (60.31%). Of the 60 with native valve endocarditis, the involved valve was mitral for most (36, 60.0%), followed by aortic (8, 13.33%), tricuspid (7, 11.66%), and pulmonary (1, 1.66%); 8 (13.33%) had both valvular and nonvalvular endocarditis. Of the 3 patients with prosthetic valve endocarditis, the involved valve was mitral for 2 and aortic for 1. Serum samples were screened for Bartonella spp. and C. burnetii by microimmunofluorescence (,). A diagnosis of endocarditis was based on an immunoglobulin (Ig) G titer >800 to phase I C. burnetii; this titer has a positive predictive value of 98% (). A diagnosis of Bartonella infection was based on the combination of a positive microimmunofluorescence titer (IgG to B. quintana or B. henselae >200) and a Western blot profile consistent with endocarditis (). Identification of the causative species was obtained by Western blot after cross-adsorption with either B. henselae or B. quintana antigens (). Antibodies to B. melitensis were detected by agglutination by using the Rose Bengal and Brucella Wright tests (both from BioRad, Hercules, CA, USA). Of the 63 patients, 9 had a positive antibody response against a tested antigen (Table): 1 to phase I C. burnetii and 8 to Bartonella spp. (IgG >200). Of these, 7 had a 1-fold dilution higher titer to B. quintana than to B. henselae, including 1 with a low-level cross-reaction with C. burnetii, and 1 had identical titers to both. For all 8 patients, Western blot results were consistent with Bartonella endocarditis. For 7, cross-adsorption identified B. quintana as the causative species; for the other, the infecting Bartonella species remained undetermined because adsorption with B. quintana and B. henselae antigens removed all antibodies. Serologic results for B. melitensis were negative for all patients.
Table

Clinical findings and causative agent for 9 patients with blood culture–negative endocarditis, India, August 2005–December 2006*

Patient age, y/sexUnderlying cardiac conditionEchocardiographic findingsIgG titer to Bartonella spp.IgG titer to Coxiella burnetii phase ICausative agent
25/FRight atrium fistulaVegetation attached to tricuspid valve400100 Bartonella quintana
46/MRheumatic heart diseaseVegetation attached
to anterior mitral
leaflet0800 Coxiella burnetii
14/MRheumatic heart diseaseVegetation attached to tip of anterior mitral leaflet2000 B. quintana
13/MRheumatic heart diseaseVegetation attached to anterior mitral leaflet2000 B. quintana
28/MBicuspid aortic valve diseaseVegetation attached to anterior coronary cusp of aortic valve4000 B. quintana
30/MRheumatic heart diseaseVegetation attached to both anterior and posterior mitral leaflet extending to chordae tendinae2000 B. quintana
50/FRheumatic heart diseaseVegetation attached to noncoronary cusp of aortic valve4000Bartonella spp.
40/MBicuspid aortic valve diseaseCalcified aortic valve4000 B. quintana
40/MDouble chamber right ventricle and subaortic perimembranous ventricular septal defectVegetation attached to right atrium anterior leaf of tricuspid valve and lateral cusp of pulmonary valve8000 B. quintana

*Ig, immunoglobulin.

*Ig, immunoglobulin. B. quintana is mostly associated with human body lice but has also been found in fleas (). The predisposing factors for B. quintana endocarditis are homelessness, alcoholism, and exposure to body lice (). For our patients, the common predisposing factors were poor hygiene and low socioeconomic status, which may expose them to ectoparasites including lice and fleas. In contrast with previous study findings, B. quintana infectious endocarditis developed on preexisting valvular lesions in all patients (). This finding may reflect a different clinical evolution than in Europe, where studies have suggested that B. quintana infectious endocarditis followed chronic bacteremia in patients who did not have previous valvular defects (). In summary, prevalence of negative blood culture among patients with infectious endocarditis was high (72%). The most commonly associated risk factor was rheumatic heart disease (Table). C. burnetii and Bartonella spp. were responsible for 8% of all infectious endocarditis cases and 14% of blood culture–negative cases. No case of infectious endocarditis caused by B. melitensis was identified. Our preliminary study suggests that zoonotic agents, especially Bartonella spp., are prevalent causative organisms of blood culture–negative endocarditis in India. We recommend serologic screening for antibodies to zoonotic microorganisms as diagnostic tools for this disease in India.
  10 in total

1.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.

Authors:  J S Li; D J Sexton; N Mick; R Nettles; V G Fowler; T Ryan; T Bashore; G R Corey
Journal:  Clin Infect Dis       Date:  2000-04-03       Impact factor: 9.079

2.  Epidemiologic and clinical characteristics of Bartonella quintana and Bartonella henselae endocarditis: a study of 48 patients.

Authors:  P E Fournier; H Lelievre; S J Eykyn; J L Mainardi; T J Marrie; F Bruneel; C Roure; J Nash; D Clave; E James; C Benoit-Lemercier; L Deforges; H Tissot-Dupont; D Raoult
Journal:  Medicine (Baltimore)       Date:  2001-07       Impact factor: 1.889

Review 3.  New insight into the diagnosis of fastidious bacterial endocarditis.

Authors:  Philippe Brouqui; Didier Raoult
Journal:  FEMS Immunol Med Microbiol       Date:  2006-06

4.  Infective endocarditis in the Western Cape Province of South Africa: a three-year prospective study.

Authors:  C F N Koegelenberg; A F Doubell; H Orth; H Reuter
Journal:  QJM       Date:  2003-03

5.  Infective endocarditis: a five-year experience at a tertiary care hospital in Pakistan.

Authors:  Muhammad Tariq; Mahboob Alam; Gulminay Munir; M Ata Khan; Raymond A Smego
Journal:  Int J Infect Dis       Date:  2004-05       Impact factor: 3.623

6.  Value of microimmunofluorescence for diagnosis and follow-up of Bartonella endocarditis.

Authors:  Pierre-Edouard Fournier; Jean-Luc Mainardi; Didier Raoult
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

7.  Molecular detection of Bartonella quintana, B. Elizabethae, B. Koehlerae, B. Doshiae, B. Taylorii, and Rickettsia felis in rodent fleas collected in Kabul, Afghanistan.

Authors:  Jean-Lou Marié; Pierre-Edouard Fournier; Jean-Marc Rolain; Sébastien Briolant; Bernard Davoust; Didier Raoult
Journal:  Am J Trop Med Hyg       Date:  2006-03       Impact factor: 2.345

8.  Western immunoblotting for Bartonella endocarditis.

Authors:  Pierre Houpikian; Didier Raoult
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

9.  Q fever serology: cutoff determination for microimmunofluorescence.

Authors:  H T Dupont; X Thirion; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  1994-03

10.  Bacterial zoonoses and infective endocarditis, Algeria.

Authors:  Akila Benslimani; Florence Fenollar; Hubert Lepidi; Didier Raoult
Journal:  Emerg Infect Dis       Date:  2005-02       Impact factor: 6.883

  10 in total
  15 in total

1.  Global trends in infective endocarditis epidemiology.

Authors:  Haur Sen Yew; David R Murdoch
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

2.  Prospective comparison of infective endocarditis in Khon Kaen, Thailand and Rennes, France.

Authors:  George Watt; Adele Lacroix; Orathai Pachirat; Henry C Baggett; Didier Raoult; Pierre-Edouard Fournier; Pierre Tattevin
Journal:  Am J Trop Med Hyg       Date:  2015-02-02       Impact factor: 2.345

3.  One-year follow-up of patients of the ongoing Dutch Q fever outbreak: clinical, serological and echocardiographic findings.

Authors:  G J M Limonard; M H Nabuurs-Franssen; G Weers-Pothoff; C Wijkmans; R Besselink; A M Horrevorts; P M Schneeberger; C A R Groot
Journal:  Infection       Date:  2010-09-21       Impact factor: 3.553

4.  Bartonella henselae endocarditis in Laos - 'the unsought will go undetected'.

Authors:  Sayaphet Rattanavong; Pierre-Edouard Fournier; Vang Chu; Khamthavy Frichitthavong; Pany Kesone; Mayfong Mayxay; Mariana Mirabel; Paul N Newton
Journal:  PLoS Negl Trop Dis       Date:  2014-12-11

5.  Unreliability of three commercial Coxiella burnetii phase II IgM ELISA kits for the seroscreening of acute Q fever in human cases.

Authors:  Selvaraj Stephen; Stanley Ambroise; Jothimani Pradeep; Dhandapany Gunasekaran; Balakrishnan Sangeetha; Kengamuthu Sarangapani
Journal:  Indian J Med Res       Date:  2017-09       Impact factor: 2.375

6.  Diagnosis of Acute Q Fever by Detection of Coxiella burnetii DNA using Real-Time PCR, Employing a Commercial Genesig Easy Kit.

Authors:  Jothimani Pradeep; Selvaraj Stephen; Stanley Ambroise; Dhandapany Gunasekaran
Journal:  J Clin Diagn Res       Date:  2017-09-01

7.  Strategy for identification & characterization of Bartonella henselae with conventional & molecular methods.

Authors:  Kavita Diddi; Rama Chaudhry; Nidhi Sharma; Benu Dhawan
Journal:  Indian J Med Res       Date:  2013-02       Impact factor: 2.375

8.  Isolation & characterization of Bartonella sp. from optic neuritis patients.

Authors:  Rama Chaudhry; Anjan Mukherjee; Vimala Menon
Journal:  Indian J Med Res       Date:  2012-12       Impact factor: 2.375

9.  Infective endocarditis in northeastern Thailand.

Authors:  George Watt; Orathai Pachirat; Henry C Baggett; Susan A Maloney; Viraphong Lulitanond; Didier Raoult; Saithip Bhengsri; Somsak Thamthitiwat; Anucha Paupairoj; Michael Kosoy; Nongrak Ud-Ai; Wichuda Sukwicha; Toni Whistler; Pierre-Edouard Fournier
Journal:  Emerg Infect Dis       Date:  2014-03       Impact factor: 6.883

Review 10.  The first reported case of Bartonella endocarditis in Thailand.

Authors:  Orathai Pachirat; Michael Kosoy; Ying Bai; Sompop Prathani; Anucha Puapairoj; Nordin Zeidner; Leonard F Peruski; Henry Baggett; George Watt; Susan A Maloney
Journal:  Infect Dis Rep       Date:  2011-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.